| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.31 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |